17 May 2023
RNZ's Kathryn Ryan talks to our Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
Related articles
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Read more
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Read more
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
Read more
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
Read more
What's next for CAR T-cell therapy
27 May 2026
Read more
Researchers explore 'RENTAL CAR' approach to CAR T-cell therapy
21 May 2026
Read more